Literature DB >> 34003176

ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections.

Colleen R Kelly1, Monika Fischer2, Jessica R Allegretti3, Kerry LaPlante4, David B Stewart5, Berkeley N Limketkai6, Neil H Stollman7.   

Abstract

Clostridioides difficile infection occurs when the bacterium produces toxin that causes diarrhea and inflammation of the colon. These guidelines indicate the preferred approach to the management of adults with C. difficile infection and represent the official practice recommendations of the American College of Gastroenterology. The scientific evidence for these guidelines was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation process. In instances where the evidence was not appropriate for Grading of Recommendations Assessment, Development, and Evaluation but there was consensus of significant clinical merit, key concept statements were developed using expert consensus. These guidelines are meant to be broadly applicable and should be viewed as the preferred, but not the only, approach to clinical scenarios.
Copyright © 2021 by The American College of Gastroenterology.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34003176     DOI: 10.14309/ajg.0000000000001278

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  22 in total

Review 1.  Is the Medium Still the Message? Culture-Independent Diagnosis of Gastrointestinal Infections.

Authors:  Neil Sood; Gary Carbell; Holly S Greenwald; Frank K Friedenberg
Journal:  Dig Dis Sci       Date:  2021-11-30       Impact factor: 3.199

2.  The evaluation of fecal microbiota transplantation vs vancomycin in a Clostridioides difficile infection model.

Authors:  Qiaomai Xu; Shumeng Zhang; Jiazheng Quan; Zhengjie Wu; Silan Gu; Yunbo Chen; Beiwen Zheng; Longxian Lv; Lanjuan Li
Journal:  Appl Microbiol Biotechnol       Date:  2022-09-10       Impact factor: 5.560

Review 3.  Next-Generation Probiotic Therapy to Protect the Intestines From Injury.

Authors:  Mecklin V Ragan; Samantha J Wala; Steven D Goodman; Michael T Bailey; Gail E Besner
Journal:  Front Cell Infect Microbiol       Date:  2022-06-28       Impact factor: 6.073

4.  Study on the Relationship between AAD and Clinical Features in Emergency Ward Patients and the Application Effect of Probiotics.

Authors:  Wenjuan Qiu; Fangfang Bai
Journal:  Contrast Media Mol Imaging       Date:  2022-07-11       Impact factor: 3.009

5.  An Unusual Presentation of Clostridioides Difficile Colitis in a Patient on Opioids.

Authors:  Oluwafemi A Ajibola; Taiwo O Aremu; Sikder Hassan; Nili Gujadhur; Valerie Cluzet
Journal:  Cureus       Date:  2022-05-29

6.  Successful Fecal Microbiota Transplant Delivered by Foley Catheter Through a Loop Ileostomy in a Patient With Severe Complicated Clostridioides difficile Infection.

Authors:  Shawn Philip; Omar Tageldin; Muhammed Sohail Mansoor; Seth Richter
Journal:  ACG Case Rep J       Date:  2022-07-12

7.  Efficacy and Outcomes of Faecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection in Children with Inflammatory Bowel Disease.

Authors:  Maribeth R Nicholson; Erin Alexander; Sonia Ballal; Zev Davidovics; Michael Docktor; Michael Dole; Jonathan M Gisser; Alka Goyal; Suchitra K Hourigan; M Kyle Jensen; Jess L Kaplan; Richard Kellermayer; Judith R Kelsen; Melissa A Kennedy; Sahil Khanna; Elizabeth D Knackstedt; Jennifer Lentine; Jeffery D Lewis; Sonia Michail; Paul D Mitchell; Maria Oliva-Hemker; Tiffany Patton; Karen Queliza; Sarah Sidhu; Aliza B Solomon; David L Suskind; Madison Weatherly; Steven Werlin; Edwin F de Zoeten; Stacy A Kahn
Journal:  J Crohns Colitis       Date:  2022-06-24       Impact factor: 10.020

8.  Real-World Comparison of Bezlotoxumab to Standard of Care Therapy for Prevention of Recurrent Clostridioides difficile Infection in Patients at High Risk for Recurrence.

Authors:  Tanner M Johnson; Kyle C Molina; Amanda H Howard; Kerry Schwarz; Lorna Allen; Misha Huang; Valida Bajrovic; Matthew A Miller
Journal:  Clin Infect Dis       Date:  2022-05-03       Impact factor: 20.999

9.  Why Do ACG and AGA Guidelines Differ for the Use of Probiotics and the Prevention of CDI?

Authors:  Lynne V McFarland; Ravina Kullar; Stuart Johnson; Jason C Sniffen; Kristin Woolard; Ellie J C Goldstein
Journal:  Am J Gastroenterol       Date:  2022-03-01       Impact factor: 12.045

10.  The Risk of Clostridioides difficile Recurrence after Initial Treatment with Vancomycin or Fidaxomicin Utilizing Cerner Health Facts.

Authors:  Ronald G Hall; Travis J Cole; Chip Shaw; Carlos A Alvarez
Journal:  Antibiotics (Basel)       Date:  2022-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.